{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:34:45Z","timestamp":1790757285134,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.drudis.2017.10.005","type":"journal-article","created":{"date-parts":[[2017,10,14]],"date-time":"2017-10-14T03:22:44Z","timestamp":1507951364000},"page":"409-415","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["Haspin: a promising target for the design of inhibitors as potent anticancer drugs"],"prefix":"10.1016","volume":"23","author":[{"given":"Nathalie Gis\u00e8le","family":"Amoussou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Bigot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Roussakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel H.","family":"Robert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2017.10.005_bib0005","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0959-440X(91)90035-R","article-title":"Eukaryotic protein kinases","volume":"1","author":"Hanks","year":"1991","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.drudis.2017.10.005_bib0010","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1096\/fasebj.9.8.7768349","article-title":"The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification","volume":"9","author":"Hanks","year":"1995","journal-title":"FASEB J."},{"key":"10.1016\/j.drudis.2017.10.005_bib0015","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1126\/science.1075762","article-title":"The protein kinase complement of the human genome","volume":"298","author":"Manning","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.drudis.2017.10.005_bib0020","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/0014-5793(94)01155-9","article-title":"Isolation and characterization of cDNA clones specifically expressed in testicular germ cells","volume":"355","author":"Tanaka","year":"1994","journal-title":"FEBS Lett."},{"key":"10.1016\/j.drudis.2017.10.005_bib0025","doi-asserted-by":"crossref","first-page":"20204","DOI":"10.1073\/pnas.0908485106","article-title":"Crystal structure of the catalytic domain of Haspin, an atypical kinase implicated in chromatin organization","volume":"106","author":"Villa","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2017.10.005_bib0030","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.molcel.2013.10.002","article-title":"Autoinhibition and Polo-dependent multisite phosphorylation restrict activity of the histone H3 kinase Haspin to mitosis","volume":"52","author":"Ghenoiu","year":"2013","journal-title":"Mol. Cell"},{"key":"10.1016\/j.drudis.2017.10.005_bib0035","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1101\/gad.1267105","article-title":"The kinase Haspin is required for mitotic histone H3 Thr 3 phosphorylation and normal metaphase chromosome alignment","volume":"19","author":"Dai","year":"2005","journal-title":"Genes Dev."},{"key":"10.1016\/j.drudis.2017.10.005_bib0040","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1126\/science.1189435","article-title":"Histone H3 Thr-3 phosphorylation by Haspin positions Aurora B at centromeres in mitosis","volume":"330","author":"Wang","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.drudis.2017.10.005_bib0045","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1126\/science.1189505","article-title":"Survivin reads phosphorylated histone H3 threonine 3 to activate the mitotic kinase Aurora B","volume":"330","author":"Kelly","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.drudis.2017.10.005_bib0050","doi-asserted-by":"crossref","first-page":"6775","DOI":"10.1038\/ncomms7775","article-title":"Borealin dimerization mediates optimal CPC checkpoint function by enhancing localization to centromeres and kinetochores","volume":"6","author":"Bekier","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drudis.2017.10.005_bib0055","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.tibs.2015.11.002","article-title":"A centromere-signaling network underlies the coordination among mitotic events","volume":"41","author":"Trivedi","year":"2016","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.drudis.2017.10.005_bib0060","doi-asserted-by":"crossref","first-page":"R966","DOI":"10.1016\/j.cub.2012.10.006","article-title":"The spindle assembly checkpoint","volume":"22","author":"Lara-Gonzalez","year":"2012","journal-title":"Curr. Biol."},{"key":"10.1016\/j.drudis.2017.10.005_bib0065","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.cub.2011.05.016","article-title":"A positive feedback loop involving haspin and aurora B promotes CPC accumulation at centromeres in mitosis","volume":"21","author":"Wang","year":"2011","journal-title":"Curr. Biol."},{"key":"10.1016\/j.drudis.2017.10.005_bib0070","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.cub.2011.03.047","article-title":"PP1\/Repo-Man dephosphorylates mitotic histone H3 at T3 and regulates chromosomal Aurora B targeting","volume":"21","author":"Qian","year":"2011","journal-title":"Curr. Biol."},{"key":"10.1016\/j.drudis.2017.10.005_bib0075","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.devcel.2011.06.020","article-title":"Repo-Man coordinates chromosomal reorganization with nuclear envelope reassembly during mitotic exit","volume":"21","author":"Vagnarelli","year":"2011","journal-title":"Dev. Cell"},{"key":"10.1016\/j.drudis.2017.10.005_bib0080","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.devcel.2006.09.018","article-title":"Regulation of mitotic chromosome cohesion by haspin and aurora B","volume":"11","author":"Dai","year":"2006","journal-title":"Dev. Cell"},{"key":"10.1016\/j.drudis.2017.10.005_bib0085","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1083\/jcb.201205106","article-title":"Haspin inhibitors reveal centromeric functions of Aurora B in chromosome segregation","volume":"199","author":"Wang","year":"2012","journal-title":"J. Cell. Biol."},{"key":"10.1016\/j.drudis.2017.10.005_bib0090","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1177\/1087057108326081","article-title":"Identification of small molecule inhibitors of the mitotic kinase Haspin by high-throughput screening using a homogeneous time-resolved fluorescence resonance energy transfer assay","volume":"13","author":"Patnaik","year":"2008","journal-title":"J. Biomol. Screen."},{"key":"10.1016\/j.drudis.2017.10.005_bib0095","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1016\/j.bmcl.2010.04.150","article-title":"Structure-activity relationship study of acridine analogs as Haspin and DYRK2 kinase inhibitors","volume":"20","author":"Cuny","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.drudis.2017.10.005_bib0100","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1042\/BJ20070797","article-title":"The selectivity of protein kinase inhibitors: a further update","volume":"408","author":"Bain","year":"2007","journal-title":"Biochem. J."},{"key":"10.1016\/j.drudis.2017.10.005_bib0105","doi-asserted-by":"crossref","first-page":"6268","DOI":"10.1111\/j.1742-4658.2008.06751.x","article-title":"DYRK1A phosphorylates caspase 9 at an inhibitory site and is potently inhibited in human cells by harmine","volume":"275","author":"Seifert","year":"2008","journal-title":"FEBS J."},{"key":"10.1016\/j.drudis.2017.10.005_bib0110","doi-asserted-by":"crossref","first-page":"6324","DOI":"10.1111\/j.1742-4658.2009.07346.x","article-title":"Harmine specifically inhibits protein kinase DYRK1A and interferes with neurite formation","volume":"276","author":"G\u00f6ckler","year":"2009","journal-title":"FEBS J."},{"key":"10.1016\/j.drudis.2017.10.005_bib0115","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/ncomms1090","article-title":"Development of a novel selective inhibitor of the Down syndrome-related kinase Dyrk1A","volume":"1","author":"Ogawa","year":"2010","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drudis.2017.10.005_bib0120","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/j.bmcl.2012.01.028","article-title":"Structure\u2013activity relationship study of beta-carboline derivatives as haspin kinase inhibitors","volume":"22","author":"Cuny","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.drudis.2017.10.005_bib0125","first-page":"3018","article-title":"Study of the cytotoxicity and metabolism of 4-amino-3-carboxamido-1-(\u03b2-d-ribofuranosyl)pyrazolo[3, 4-d]pyrimidine using inhibitors of adenosine kinase and adenosine deaminase","volume":"39","author":"Wotring","year":"1979","journal-title":"Cancer Res."},{"key":"10.1016\/j.drudis.2017.10.005_bib0130","doi-asserted-by":"crossref","first-page":"20523","DOI":"10.1073\/pnas.0708800104","article-title":"A systematic interaction map of validated kinase inhibitors with Ser\/Thr kinases","volume":"104","author":"Fedorov","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2017.10.005_bib0135","doi-asserted-by":"crossref","first-page":"20198","DOI":"10.1073\/pnas.0901989106","article-title":"Structure and functional characterization of the atypical human kinase haspin","volume":"106","author":"Eswaran","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2017.10.005_bib0140","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.chembiol.2011.04.013","article-title":"A General framework for inhibitor resistance in protein kinases","volume":"18","author":"Balzano","year":"2011","journal-title":"Chem. Biol."},{"key":"10.1016\/j.drudis.2017.10.005_bib0145","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1083\/jcb.201205119","article-title":"A small-molecule inhibitor of Haspin alters the kinetochore functions of Aurora B","volume":"199","author":"De Antoni","year":"2012","journal-title":"J. Cell. Biol."},{"key":"10.1016\/j.drudis.2017.10.005_bib0150","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1038\/onc.2011.335","article-title":"Antitumor activity of a small-molecule inhibitor of the histone kinase Haspin","volume":"31","author":"Huertas","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.drudis.2017.10.005_bib0155","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1021\/bc500464r","article-title":"Bisubstrate inhibitor approach for targeting mitotic kinase Haspin","volume":"26","author":"Kestav","year":"2015","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.drudis.2017.10.005_bib0160","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/cmdc.200900252","article-title":"Bisubstrate inhibitors of protein kinases: from principle to practical applications","volume":"5","author":"Lavogina","year":"2010","journal-title":"Chem. Med. Chem."},{"key":"10.1016\/j.drudis.2017.10.005_bib0165","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.bbapap.2009.10.019","article-title":"Bisubstrate fluorescent probes and biosensors in binding assays for HTS of protein kinase inhibitors","volume":"1804","author":"Uri","year":"2010","journal-title":"Biochim. Biophys. Acta"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644616304160?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644616304160?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T12:35:33Z","timestamp":1761222933000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644616304160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S1359644616304160"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2017.10.005","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Haspin: a promising target for the design of inhibitors as potent anticancer drugs","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2017.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}